Streetbeat News

Products Services

URGN

UroGen Pharma Ltd. announced promising long-term results from its Phase 3 ENVISION trial for UGN-102, a potential treatment for LG-IR-NMIBC. This could lead to the first FDA-approved treatment for this condition.

Portfolio Pulse from

December 05, 2024 | 8:30 pm

NVDA

Nvidia's Q3 marks the beginning of the ramp-up phase for its Blackwell AI chips. Despite some technical issues and business risks, such as exposure to China, the chips' computing performance, bandwidth, and energy efficiency are key strengths.

Portfolio Pulse from

December 05, 2024 | 8:15 pm

EXPI

Joshua Smith, a leading realtor with two decades of experience, has joined eXp Realty. Smith is known for his record-breaking closings and aims to empower 40,000 agents worldwide.

Portfolio Pulse from

December 05, 2024 | 8:15 pm

MA

Mastercard's stock has risen by 16.1% over the past six months, driven by diversified revenue streams and a strong core business. The shift to digital payments is expected to further support the company's performance.

Portfolio Pulse from

December 05, 2024 | 8:15 pm

UNH

UnitedHealth Group is focusing on value-based care and AI to improve efficiencies and patient outcomes. The company reported a 9% increase in third-quarter revenues, reaching $101 billion, driven by Optum Health and Optum Rx. Despite challenges like Medicare rate cuts and cyberattacks, UnitedHealth maintains its 2024 earnings outlook.

Portfolio Pulse from

December 05, 2024 | 8:00 pm

MKTX

MarketAxess (MKTX) is recommended for portfolio addition due to its growth potential driven by increased commission revenues, a diversified product portfolio, and a strong financial position.

Portfolio Pulse from

December 05, 2024 | 8:00 pm

HOOD

Robinhood CEO Vlad Tenev expressed optimism about the Trump administration's understanding of Bitcoin and crypto, suggesting the potential for a Bitcoin strategic reserve.

Portfolio Pulse from

December 05, 2024 | 8:00 pm

MRNA

Moderna, Inc. participated in the Piper Sandler 36th Annual Healthcare Conference, with CEO Stephane Bancel representing the company. The event was held on December 5, 2024.

Portfolio Pulse from

December 05, 2024 | 8:00 pm

BLK

Jay Jacobs from BlackRock suggests that the impact of AI on markets will be larger than previously anticipated as it enters its third year of the 'build phase', despite geopolitical risks.

Portfolio Pulse from

December 05, 2024 | 8:00 pm